Brainsway (BWAY) has released an update.
BrainsWay Ltd., a leader in noninvasive neurostimulation treatments for mental health, has appointed Dr. Richard A. Bermudes as its new Chief Medical Officer. Dr. Bermudes brings over 20 years of experience in TMS and brain stimulation therapies to the company. This strategic hire is aimed at advancing BrainsWay’s clinical strategy and product development in the mental health sector.
For further insights into BWAY stock, check out TipRanks’ Stock Analysis page.
